The digital healthcare company Hims & Hers narrowed its full-year revenue outlook after third-quarter sales came in lower than expected. The company reported weaker-than-anticipated Q3 results, prompting a downward revision of its annual revenue guidance. While specific figures were not detailed in the brief report, the adjustment reflects ongoing challenges in meeting growth targets in the competitive telehealth space.
The revision signals caution among investors as the firm navigates market pressures and evolving consumer demand for digital health services.
Source: Wall Street Journal US Business · Summarized by HeadlinesBriefing